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Abstract
Background: People who rate their health as poor experience higher all-cause mortality. Study of disease-specific
association with self-rated health might increase understanding of why this association exists.
Objectives: To estimate the strength of association between self-rated health and fatal and non-fatal cardiovascular disease.
Methods: A comprehensive search of PubMed MEDLINE, EMBASE, CINAHL, BIOSIS, PsycINFO, DARE, Cochrane Library, and
Web of Science was undertaken during June 2013. Two reviewers independently searched databases and selected studies.
Inclusion criteria were prospective cohort studies or cohort analyses of randomised trials with baseline measurement of self-
rated health with fatal or non-fatal cardiovascular outcomes. 20 studies were pooled quantitatively in different meta-
analyses. Study quality was assessed using Newcastle-Ottawa scales.
Results: ‘Poor’ relative to ‘excellent’ self-rated health (defined by most extreme categories in each study, most often’ poor’
or ‘very poor’ and ‘excellent’ or ‘good’) was associated over a follow-up of 2.3–23 years with cardiovascular mortality in
studies: where varying degrees of adjustments had been made for cardiovascular disease risk (HR 1.79 (95% CI 1.50 to 2.14);
15 studies, I2 = 71.24%), and in studies reporting outcomes in people with pre-existing cardiovascular disease or ischaemic
heart disease symptoms (HR 2.42 (95% CI 1.32 to 4.44); 3 studies; I2 = 71.83%). ‘Poor’ relative to ‘excellent’ self rated health
was also associated with the combined outcome of fatal and non-fatal cardiovascular events (HR 1.90 (95% CI 1.26 to 2.87);
5 studies; I2 = 68.61%), Self-rated health was not significantly associated with non-fatal cardiovascular disease outcomes (HR
1.66 (95% CI 0.96 to 2.87); 5 studies; I2 = 83.60%).
Conclusions: Poor self rated health is associated with cardiovascular mortality in populations with and without prior
cardiovascular disease. Those with current poor self-rated health may warrant additional input from health services to
identify and address reasons for their low subjective health.
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Introduction
Self-rated health (SRH), a simple measure of subjective health
status, strongly and consistently predicts all-cause mortality across
varied populations even after adjustment for demographic,
biophysical, and behavioural risk factors. [1,2] The reasons
behind this are uncertain. SRH may be a sensitive reflection of
current underlying disease or proxy for a subclinical state - a
measure of the awareness of symptoms, disease or risk factors; or
alternatively a reflection of personal characteristics that may
impact upon future health outcomes [2–5].
Studies of SRH have primarily studied its’ relationship with all-
cause mortality.[1] All-cause mortality is objective, relatively easy
to collect and comparable across populations. It is, however, a
blunt instrument for analysing causal pathways. The study of SRH
in specific diseases may be an important step in the understanding
of the relationship between SRH and mortality. A further benefit
of shifting the focus of SRH research to its relationship with
specific disease incidence and disease outcomes is that better
specification and measurement of relevant covariates may also
provide more precise estimates of any independent effect of SRH.
Such information could be used to assess the potential use of SRH
for risk prediction in specific diseases. In addition, important
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differences may exist in the relationship between self-rated health
and mortality among those with and without specific pre-existing
disease, which may be obscured in available studies which have
not characterized populations in this way, focusing mainly on
large, heterogeneous samples of national or regional populations.
[6] For example, Idler et al found that SRH predicts subsequent
mortality more strongly in those with circulatory system disease
than in those with no identified cardiovascular condition. [7].
The relationship between SRH and mortality has been shown
to vary by disease. In a unique analysis of 700,000 American
National Health Interview Survey participants followed for over
20 years, self-rated health strongly predicted death from diabetes,
infectious, and respiratory diseases, (HR of 6.1, 3.7, 3.7
respectively), and a to a lesser extent from coronary heart disease
(HR of 2.3) and cancer (HR of 1.6) [6] A more recent study in
2013 of 4770 mid-life adults participating in the US Health and
Retirement study also found SRH to be a significant predictor of
onset of chronic conditions including coronary heart disease,
stroke, diabetes, lung disease and arthritis. [8] This link between
SRH and morbidity is, however, less certain and it is unclear
whether the relationship between SRH and all-cause mortality is
mediated through disease-specific morbidity pathways.
This meta-analysis was undertaken to collate evidence from
individual studies and examine the association across studies
between SRH and cardiovascular disease-specific mortality and
morbidity. Cardiovascular disease including stroke was chosen
since it remains the most important cause of morbidity and
mortality in many countries and because its epidemiology is well
established, facilitating better measurement and control of
covariates in study design and analysis. It has been speculated
that the association of poor self-rated health with all-cause
mortality may be driven by its association with cardiovascular
diseases.[9] No formal meta-analyses have previously explored the
relationship between SRH and CVD mortality or morbidity.
Materials and Methods
A comprehensive search of the following electronic resources
was undertaken during June 2013: PubMed MEDLINE,
EMBASE, CINAHL, BIOSIS, PsycINFO, DARE, Cochrane
Library, and Web of Science. Search strategies were tailored to
each database using a combination of indexed headings and text
words; a sample search is included in the Appendix. Two
reviewers independently searched the databases, selected the
studies and reviewed the contents of the manuscripts to determine
whether they met the criteria for inclusion. Data were then
independently extracted and quality assessment performed. When
discrepancies occurred between reviewers in determining inclusion
into the analyses, other authors were asked to evaluate the studies.
No language or time restrictions were imposed. Authors of
primary studies and experts in the field were contacted to answer
questions about methodology or study results. For the systematic
review, studies had to meet the following inclusion criteria: (a)
adult populations (b) current self-rated health measured by a single
question at the beginning of follow-up, with clearly defined and
similar response categories (c) prospective cohort study, cohort
analysis of randomised trials or incident (nested) case-control study
(d) reporting non-fatal events and/or fatal outcomes for coronary
heart disease, stroke, or combined CVD. Assessment of study
quality was primarily concerned with identifying risk of bias,
rather than merely examining the quality of article reporting [10]
using the Newcastle-Ottawa scales. [11].
Studies were sub-divided into those reporting: (i) fatal CVD
events or mortality outcomes in both population studies and in
those reporting outcomes in people with pre-existing cardiovas-
cular disease or ischaemic heart disease symptoms (ii) those with
non-fatal CVD events only (iii) and those with combined fatal and
non-fatal CVD events.
We combined log-hazard ratios for appropriate subsets of
individual studies using random-effects meta-analyses, and pre-
sented corresponding forest plots of hazard ratios with a diamond
Figure 1. Prisma Flow Diagram.
doi:10.1371/journal.pone.0103509.g001
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ndicating the summary effect estimate and 95% confidence
interval. Box sizes were drawn inversely proportional to the
magnitude of the standard error for each study and indicate the
relative weight of each study in the meta-analysis. Where there was
more than one CVD outcome per study or analyses on two or
more patient samples, the effect sizes for each outcome/patient
sample were averaged using a fixed effects meta-analysis to
generate a single effect size for each study. The meta-analysis
focussed on the comparison of patients reporting poor health
relative to excellent health, via hazard ratios. For studies analysing
ordered categories, we used the categories at each end of the Likert
scale (labelled as ‘‘excellent’’ self-rated health - reference category-
and ‘‘poor’’ respectively). A number of studies collapsed their self-
rated health categories into a dichotomous variable, likely to
ensure adequate numbers for analysis. For these, the highest SRH
category analysed was used as the ‘‘excellent’’ reference category
and the comparison category labelled ‘‘poor’’ self-rated health.
Heterogeneity between studies was assessed using the Q-test for
heterogeneity and I2-statistic, based on the DerSimonian-Laird
estimator. Publication bias was assessed using a funnel plot and a
rank correlation test for funnel plot asymmetry. [12] Sensitivity
analyses were performed excluding studies that had used different
patient populations or non-standard outcome measures. The
‘metafor’ package in R software (R Development Core Team,
2012) was used to conduct all meta-analyses.[13,14] The article
was drafted using the PRISMA reporting guidelines. [15].
Results
Figure 1 shows the number of records identified, screened and
excluded. 42 studies were identified as being potentially relevant
(including four non-English articles which were translated), of
which 24 met the inclusion criteria. Four of these were
subsequently excluded from the meta-analyses: two were matched
case-control studies with results expressed as conditional odds
ratios; [16,17] one only reported proportional hazard ratios and
inexact p values; [8] and one only reported on combined risk of
stroke recurrence and death in a stroke population. [18] Appels
(1996) reported two sets of results for Lithuania and the
Netherlands. These were treated as separate studies because the
analysis was applied to two distinct populations. [9].
Study characteristics and participants
Details of the 20 studies included in the various meta-analyses
are presented in Table 1. [6,7,9,19–34] Thirteen populations
studied were in Europe, 5 in the USA and 2 in Asia. Sample sizes
ranged from 234 to 689,710 and follow-up ranged from 2.3–23
years, with most studies reporting results from more than 5 years
follow-up. Study participants were mostly middle-aged or older
adults, with six studies conducted exclusively in men,
[9,26,27,30,34] and two exclusively in women.[29,31] Other than
three studies based on persons with pre-existing cardiovascular
disease or ischaemic heart disease symptoms, [7,19,31] the focus
was on populations without, or controlling for previous CVD
events or risk. Characterisation of populations varied with the
majority assessing sociodemographic factors and classic CVD risk
factors (blood pressure, blood glucose, lipids, alcohol, BMI,
smoking, physical activity) but varying in inclusion of other factors
such as education or socioeconomic status [7,20,33] and diagnoses
of other diseases such as depression [19,21,28,29,31] or diabetes
[9,19,21,29,32]. Only two studies included family history of CVD.
[30,33] One study assessed objective measures of lifestyle with
vitamin C levels. [33] Health service utilisation was not reported in
any of the studies. CVD mortality was the predominant outcome
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reported; five studies separately reported incidence of a non-fatal
CVD event.[9,20,28,33] There was generally poor measurement
of disease severity in studies. Table 2 outlines the risk of bias in
included studies based on the Newcastle-Ottawa Quality Assess-
ment Scales. Visual inspection of the funnel plots for each analysis
(figure 2) and the results of the rank correlation tests suggest that
publication bias was unlikely, with an even distribution of study
effect sizes plotted against precision in the funnel plots and
relatively high P-values in the statistical tests. Sensitivity analyses
are shown in Table 3.
Meta-analysis findings
1. Fatal CVD events. Figure 3 shows the results of a meta-
analysis of log-hazard ratios of poor health relative to excellent
health for CVD mortality from studies of 15 unselected
populations ranging from 783 to 689,710 participants where
varying adjustments were made for baseline CVD status or risk.
All studies were well-controlled for confounders except Wanna-
methee (1991) and Dog˘anay (2012) (see table 1). A weighted
average was taken for the Wannamethee (1991) study because they
reported results from different age subgroups and for the Heistaro
(2001) and Ernsten (2011) studies, because they reported both
male and female results. The combined summary estimate for the
hazard ratio of poor relative to excellent health was 1.79 (95% CI
1.50 to 2.14), but there was significant heterogeneity as shown by
the I2–statistic (I2 = 71.24%) and Q-test statistic (Q-test statistic of
48.7 (p,0.0001)). However, the I2 statistic was 0 if the meta-
analysis was restricted to studies containing elderly populations, or
to studies of men which were well controlled for covariates. In
both cases, the summary estimate (hazard ratio) for CVD mortality
for excellent to poor health was reduced. (See table 3). There was
no significant effect of number of years of follow-up on the
summary estimate (p = 0.059). The hazard ratio for CVD
mortality was significantly lower as year of publication increased
(p = 0.023), but still remained highly significant: HR 1.64 (95% CI
1.33 to 2.02, p,0.001) when including only studies published
post-2000 in the meta-analysis.
Figure 3 also shows the results of a meta-analysis of log-hazard
ratios of poor relative to excellent health for CVD mortality from
studies of individuals with pre-existing cardiovascular disease or
ischaemic heart disease symptoms. The combined summary
estimate for the hazard ratio for these studies was 2.42 (95% CI
Figure 2. Funnel plot of standard error against effect size (log hazard ratio) for (a) CVD mortality meta-analysis [Kendal’s
tau=2.20, p= .82] (b) CVD mortality meta-analysis (existing CVD) [Kendal’s tau=2.33, p=1.00] (c) Non-fatal CVD events meta-
analysis [Kendal’s tau=2.24, p= .24] (d) Fatal and non-fatal CVD events combined meta-analysis: [Kendal’s tau=2.24, p= .24].
doi:10.1371/journal.pone.0103509.g002
Self-Rated Health and Cardiovascular Disease
PLOS ONE | www.plosone.org 8 July 2014 | Volume 9 | Issue 7 | e103509
1.32 to 4.44), again with significant heterogeneity (Q test 7.10,
p = 0.03). There was no significant effect of number of years of
follow-up or year of publication on the summary estimate.
2. Non-fatal CVD events. Figure 4 shows the results of a
meta-analysis of hazard ratios of poor health relative to excellent
health for non-fatal CVD events from studies of unselected
populations. The combined summary estimate for the hazard ratio
was 1.66 (95% CI 0.96 to 2.87), and again there was significant
heterogeneity, with a Q-test of 24.39, which was highly significant
(p,0.0001). The heterogeneity, and hazard ratio was greatly
reduced if the van der Linde study was omitted (table 3).
3. Combined fatal and non-fatal CVD events. Figure 5
shows the results of a meta-analysis of hazard ratios of poor health
relative to excellent health for combined fatal and non-fatal CVD
events from studies of unselected populations. The combined
summary estimate for the hazard ratio was 1.90 (95% CI 1.26 to
2.87). The I2-statistic was 68.61%, falling to 0% without loss of
significance after excluding van der Linde (2013) (see table 3). The
Q-test for heterogeneity produced a test statistic of 12.74, which
was significant (p = 0.013). There was no significant effect of
number of years of follow-up on the summary estimate but the
odds ratio for fatal and non-fatal CVD combined events was
significantly higher for more recent publications (p = 0.012).
Discussion
Summary of findings
Our meta-analysis demonstrates a significant association
between SRH and CVD mortality. This was present in
populations with pre-existing disease and also in those where
efforts were made to control for disease. Compared with excellent
health, poor self-rated health was associated with more than one
and a half times the risk of CVD mortality even after maximal
adjustment for risk factors (including psychosocial factors, health
behaviours and health service utilisation in some studies). This is
comparable to but somewhat less than the effect size observed for
SRH with all-cause mortality in other studies (HR for poor versus
excellent 1.92 (95%CI (1.64, 2.25)).[1] The effect size (poor versus
Table 3. Sensitivity analysis – impact of excluding studies.
Studies included in
meta-analysis
No. of
studies Excluding
Summary estimate
(95% CI) I2-statistic
Fatal CVD
All studies 15 None 1.79 (1.50 to 2.14) 71.24%
Well-controlled for confounders 13 Dog˘anay, Wannamethee 1.67 (1.41 to 1.98) 66.70%
Middle-aged or general population studies 8 Ferna´ndez-Ruiz, Dog˘anay, Ernsten,
Kamphuis, Fang, Tsuji, Pijls
1.90 (1.51 to 2.39) 75.41%
Elderly population only (65 years and older
expect Fang (2003) over 55 years)
7 van der Linde, Benjamins, Heidrich,
Heistaro, Kaplan, Appels, Wannamethee
1.50 (1.27 to 1.76) 0%
Male populations only 9 van der Linde, Ferna´ndez-Ruiz, Dog˘anay,
Benjamins, Fang, Tsuji
1.74 (1.36 to 2.23) 70.03%
Well-controlled studies based on male
populations only
8 van der Linde, Ferna´ndez-Ruiz, Dog˘anay,
Benjamins, Fang, Tsuji, Wannamethee
1.52 (1.34 to 1.72) 0%
Both male and female populations 8 Pijls, Appels, Kaplan, Heidrich, Kamphuis,
Wannamethee
1.68 (1.32 to 2.12) 78.56%
All except Benjamins 14 Benjamins (non-proportional hazards) 1.73 (1.45 to 2.05) 51.26%
Pre-existing Disease
All 3 None 2.42 (1.32 to 4.44). 71.83%
Excluding female studies 2 Rutledge 2.34 (1.09 to 5.06) 84.95%
Non-fatal CVD
All studies 5 None 1.66 (0.96 to 2.87) 83.60%
Middle-aged patient population* 3 Kennedy, Dog˘anay 1.80 (0.81 to 4.02) 87.14%
Well-controlled for confounders 4 Dog˘anay 1.60 (0.82 to 3.14) 87.67%
All except Van der Linde (2013) 4 van der Linde (heavily influences
between-study heterogeneity)
1.34 (0.97 to 1.86) 27.24%
All except Van der Linde (2013) and Dog˘anay (2012) 3 van der Linde, Dog˘anay 1.23 (0.85 to 1.77) 27.47%
Fatal and non-fatal CVD
All studies 5 None 1.90 (1.26 to 2.87) 68.61%
Well-controlled for confounders 4 Dog˘anay 1.84 (1.10 to 3.09) 76.26%
Middle-aged patient population* 3 Pijls, Dog˘anay 2.08 (1.21 to 3.56) 79.42%
Male subjects only 2 Kuper, Dog˘anay, van der Linde 1.39 (0.92 to 2.08) 0%
All except Van der Linde (2013) 4 van der Linde 1.60 (1.21 to 2.13) 0%
*Using standard SRH scale only.
doi:10.1371/journal.pone.0103509.t003
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excellent SRH) was higher among those people with pre-existing
cardiovascular disease or ischaemic heart disease symptoms; poor
SRH was associated with more than twice the risk of CVD
mortality after adjusting for disease severity in some studies. A
significant relationship between SRH and cardiovascular outcome
was also found in studies combining fatal and non-fatal CVD
outcomes. While the observed association of SRH with non-fatal
CVD events was of similar magnitude (HR 1.66), this was not
statistically significant.
These findings need to be interpreted in the light of the
observed heterogeneity. Both the size of the association with
cardiovascular mortality and the degree of heterogeneity was
reduced if the analysis was restricted to elderly populations, or
male populations with good control of covariates. This suggests
that our summary estimates of the association of SRH with
cardiovascular mortality were probably inflated through inade-
quate adjustment for different participant characteristics in some
of the studies. Heterogeneity in studies included in the meta-
analysis of SRH and non-fatal CVD outcomes was considerably
reduced by excluding van der Linde et al (2013), which found the
strongest association between SRH and non-fatal CVD outcomes
(3.54 95%CI (2.57,4.87)), but a weaker association with cardio-
vascular mortality than the other studies. The van der Linde study
however was of high quality. It was carried out in a large
population of over 16,000 men and women with over 10 years of
follow-up, and with particular efforts made to exclude from the
analyses those with pre-existing disease (i.e. reporting a diagnosis
of stroke, heart attack or angina). Adjustments were also made for
Figure 3. Meta-analysis of fatal CVD events in populations with varying degrees of control for CVD status and risk factors* and
those with pre-existing disease: Poor health relative to excellent health.
doi:10.1371/journal.pone.0103509.g003
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Figure 4. Meta-analysis of non-fatal CVD events in unselected populations with varying degrees of control for CVD status and risk
factors: Poor health relative to excellent health.
doi:10.1371/journal.pone.0103509.g004
Figure 5. Meta-analysis of fatal and non-fatal CVD events in unselected populations with varying degrees of control for CVD status
and risk factors: Poor health relative to excellent health.
doi:10.1371/journal.pone.0103509.g005
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cardiovascular risk at baseline including behavioural factors and
dietary measures, and outcomes were robustly defined and
measured. Other studies had not excluded prevalent disease as
thoroughly, or had included older cohorts where results were more
likely to reflect current ill health. van der Linde also had more
complete ascertainment of fatal CVD and of confirmed diagnosis
of non-fatal CVD outcomes through hospital admission identified
from participants’ National Health Service number through data
linkage with Health Authority databases. This study therefore
perhaps provides the most reliable estimates of the association of
SRH with confirmed cardiovascular morbidity. Indeed, a more
recent study not included in the meta-analysis due to statistical
non-conformity with other included studies, also found a
significant association between SRH and onset of non-fatal
CVD (HR 1.25 for CHD and 1.54 for stroke p,= .001). In this
study the strength of the association was closer to the other studies
in this meta-analysis than to van der Linde, perhaps because it
relied on a weaker method of ascertaining outcome (self report of
physician diagnosis). [8].
Limitations
There are still surprisingly few high quality studies in this area.
We found only 5 cohorts reporting on the incidence or recurrence
of non-fatal CVD, only 5 studies reporting combined fatal and
non-fatal CVD events, and only 3 studies of fatal CVD events in
those with pre-existing cardiovascular disease or ischaemic heart
disease symptoms. There were methodological problems with
many of the included studies, including poor measurement of
baseline risk and CVD status (e.g. self-report versus objectively
diagnosed), lack of detail of study methods and poor ascertainment
of disease status and severity. We used a random-effects method of
analysis because of the heterogeneity, but this results in smaller
studies being given a greater relative weight than if a fixed effects
method was performed.[35] This is a concern if the smaller studies
were also those of the lowest quality. Nevertheless, we believe that
our use of sensitivity analyses helped to address this problem. For a
few studies where the 95% CI’s were not symmetric on the log-
scale, the hazard ratios and 95% confidence intervals as presented
in the forest plots do not exactly match those given in the original
studies. This is because the hazard ratios and confidence intervals
were transformed to the log-scale prior to analysis, with the process
of extracting the standard error from the 95% CI on the log-scale
and back-transformation resulting in slightly different numbers for
the forest plots, mostly likely due to rounding or presentational
error in the original studies. It was also not possible to adjust for
later changes in covariates which may have taken place over the
course of studies, and which may have impacted upon SRH (e.g.
smoking and physical activity). There are also limitations with
using the most extreme categories of SRH in each study in the
meta-analysis. These include reducing the statistical power and
potentially producing higher hazard ratios due to discarding a
proportion of the sample. Finally, the clinical significance of the
reported relationships is unknown, particularly in light of CVD
being a heterogeneous category of conditions including coronary
heart disease, and stroke with overlapping but distinct pathophys-
iological processes.
SRH, mortality and disease
The association of SRH with CVD mortality found in our meta-
analysis is likely to explain some but not all of the relationship
between SRH and all-cause mortality. It nevertheless remains an
important finding, in particular in view of the fact that in many of
the studies included in the meta-analysis, adequate adjustment for
covariates including traditional Framingham CV risk factors was
undertaken. The most important hypothesis to explain the
relationship between SRH and all-cause or disease-specific
mortality is that subjective assessment of SRH is also a sensitive
measure of objective health status. If this is so, precision of
measurement of disease correlates, and better adjustment should
decrease the strength of the association, which studies including
better measurement of covariates may account for. Our meta-
analysis did confirm that the strength of the association was
reduced (but remained significant) if only well-controlled studies
for cardiovascular risk were included. Secondly the association
between SRH and mortality outcomes may reflect a personal
predisposition to better or worse health, not related to objective
health status at the time of questioning. The predisposition might
be rooted in a range of health-protective factors, including
biophysical factors; immune responses or neuro-endocrine ho-
moeostasis, behavioural factors; diet, physical activity, smoking
- usually adjusted for in studies, and psycho-social factors (positive
affect, sense of coherence, or coping style). [36–41] Thirdly,
the relationship between self-rated health and mortality may be
mediated by functional limitations and decline or disability
resulting from morbidity, supported by the strong relationship
observed between self-rated and functional health. [2,42] Rutledge
et al in their sample of women with CVD symptoms found that
SRH scores most closely overlapped with functional impairment
status. [31] Even those without known CVD may be aware of
early changes in functional ability, which are then reflected in
overall self-ratings. [4] The stronger association of SRH with
mortality in those with pre-existing diagnosis of cardiovascular
disease supports the hypothesis that participant knowledge of
disease status may affect SRH and its association with mortality.
[7,31].
Conclusions
This study suggests that standard CVD risk factors and disease
severity measures may underestimate risks of clinical cardiac
events and that self-ratings may convey additional knowledge that
may not be completely captured by epidemiological or available
clinical measurement. The use of SRH as an additional risk factor
in traditional cardiovascular risk prediction models or as part of a
simple non-invasive risk score acceptable to patients in primary
care therefore requires further investigation. It is uncertain when
would be the best time to measure SRH for purposes of accurate
outcome prediction. There is also uncertainty around whether
SRH is in fact modifiable and if any improvements in SRH may
result in improved cardiovascular outcomes. Nevertheless, those
with poor self-rated health at cardiovascular risk in both non-
clinical and clinical populations may warrant additional input
from health services to identify and address reasons for their low
subjective health.
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